Garuda Therapeutics

Recent Finacing

Series A I

Recent Raise

$50M

Garuda Therapeutics develops an off‑the‑shelf platform to produce self‑renewing, HLA‑compatible, transgene‑free blood stem cells and HSC‑derived immune cells for scalable transplantation and oncology applications.

Founded 2021

Massachusetts, United States

51-100

Private

garudatx.com

Highlights

Focus Areas

Biotechnology

Health Care

Life Science

Therapeutics

Recent Investors

Financials

$184M

Total Raised

3

Funding rounds

11

Investors

Team

Upgrade to view the team

See the team members at Garuda Therapeutics.